The prothrombotic activity of cancer cells in the circulation

Annachiara Mitrugno, Garth W. Tormoen, Peter Kuhn, Owen McCarty

Research output: Contribution to journalArticle

32 Citations (Scopus)

Abstract

The hemostatic system is often subverted in patients with cancer, resulting in life-threatening venous thrombotic events. Despite the multifactorial and complex etiology of cancer-associated thrombosis, changes in the expression and activity of cancer-derived tissue factor (TF) - the principle initiator of the coagulation cascade - are considered key to malignant hypercoagulopathy and to the pathophysiology of thrombosis. However, many of the molecular and cellular mechanisms coupling the hemostatic degeneration to malignancy remain largely uncharacterized. In this review we discuss some of the tumor-intrinsic and tumor-extrinsic mechanisms that may contribute to the prothrombotic state of cancer, and we bring into focus the potential for circulating tumor cells (CTCs) in advancing our understanding of the field. We also summarize the current status of anti-coagulant therapy for the treatment of thrombosis in patients with cancer.

Original languageEnglish (US)
Pages (from-to)11-19
Number of pages9
JournalBlood Reviews
Volume30
Issue number1
DOIs
StatePublished - Jan 1 2016

Fingerprint

Neoplasms
Thrombosis
Hemostatics
Circulating Neoplastic Cells
Coagulants
Thromboplastin
Therapeutics

Keywords

  • Cancer
  • Circulating tumor cells
  • Coagulation
  • Platelets
  • Thrombosis
  • Tissue factor

ASJC Scopus subject areas

  • Hematology
  • Oncology

Cite this

The prothrombotic activity of cancer cells in the circulation. / Mitrugno, Annachiara; Tormoen, Garth W.; Kuhn, Peter; McCarty, Owen.

In: Blood Reviews, Vol. 30, No. 1, 01.01.2016, p. 11-19.

Research output: Contribution to journalArticle

Mitrugno, Annachiara ; Tormoen, Garth W. ; Kuhn, Peter ; McCarty, Owen. / The prothrombotic activity of cancer cells in the circulation. In: Blood Reviews. 2016 ; Vol. 30, No. 1. pp. 11-19.
@article{f5927f1250f34552903fd7a7aa11d6ef,
title = "The prothrombotic activity of cancer cells in the circulation",
abstract = "The hemostatic system is often subverted in patients with cancer, resulting in life-threatening venous thrombotic events. Despite the multifactorial and complex etiology of cancer-associated thrombosis, changes in the expression and activity of cancer-derived tissue factor (TF) - the principle initiator of the coagulation cascade - are considered key to malignant hypercoagulopathy and to the pathophysiology of thrombosis. However, many of the molecular and cellular mechanisms coupling the hemostatic degeneration to malignancy remain largely uncharacterized. In this review we discuss some of the tumor-intrinsic and tumor-extrinsic mechanisms that may contribute to the prothrombotic state of cancer, and we bring into focus the potential for circulating tumor cells (CTCs) in advancing our understanding of the field. We also summarize the current status of anti-coagulant therapy for the treatment of thrombosis in patients with cancer.",
keywords = "Cancer, Circulating tumor cells, Coagulation, Platelets, Thrombosis, Tissue factor",
author = "Annachiara Mitrugno and Tormoen, {Garth W.} and Peter Kuhn and Owen McCarty",
year = "2016",
month = "1",
day = "1",
doi = "10.1016/j.blre.2015.07.001",
language = "English (US)",
volume = "30",
pages = "11--19",
journal = "Blood Reviews",
issn = "0268-960X",
publisher = "Churchill Livingstone",
number = "1",

}

TY - JOUR

T1 - The prothrombotic activity of cancer cells in the circulation

AU - Mitrugno, Annachiara

AU - Tormoen, Garth W.

AU - Kuhn, Peter

AU - McCarty, Owen

PY - 2016/1/1

Y1 - 2016/1/1

N2 - The hemostatic system is often subverted in patients with cancer, resulting in life-threatening venous thrombotic events. Despite the multifactorial and complex etiology of cancer-associated thrombosis, changes in the expression and activity of cancer-derived tissue factor (TF) - the principle initiator of the coagulation cascade - are considered key to malignant hypercoagulopathy and to the pathophysiology of thrombosis. However, many of the molecular and cellular mechanisms coupling the hemostatic degeneration to malignancy remain largely uncharacterized. In this review we discuss some of the tumor-intrinsic and tumor-extrinsic mechanisms that may contribute to the prothrombotic state of cancer, and we bring into focus the potential for circulating tumor cells (CTCs) in advancing our understanding of the field. We also summarize the current status of anti-coagulant therapy for the treatment of thrombosis in patients with cancer.

AB - The hemostatic system is often subverted in patients with cancer, resulting in life-threatening venous thrombotic events. Despite the multifactorial and complex etiology of cancer-associated thrombosis, changes in the expression and activity of cancer-derived tissue factor (TF) - the principle initiator of the coagulation cascade - are considered key to malignant hypercoagulopathy and to the pathophysiology of thrombosis. However, many of the molecular and cellular mechanisms coupling the hemostatic degeneration to malignancy remain largely uncharacterized. In this review we discuss some of the tumor-intrinsic and tumor-extrinsic mechanisms that may contribute to the prothrombotic state of cancer, and we bring into focus the potential for circulating tumor cells (CTCs) in advancing our understanding of the field. We also summarize the current status of anti-coagulant therapy for the treatment of thrombosis in patients with cancer.

KW - Cancer

KW - Circulating tumor cells

KW - Coagulation

KW - Platelets

KW - Thrombosis

KW - Tissue factor

UR - http://www.scopus.com/inward/record.url?scp=84960224716&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84960224716&partnerID=8YFLogxK

U2 - 10.1016/j.blre.2015.07.001

DO - 10.1016/j.blre.2015.07.001

M3 - Article

C2 - 26219246

AN - SCOPUS:84960224716

VL - 30

SP - 11

EP - 19

JO - Blood Reviews

JF - Blood Reviews

SN - 0268-960X

IS - 1

ER -